Shortening the Duration of Tuberculosis Chemotherapy

The 2019 Conference on Tuberculosis Drug Discovery and Development will feature presentations on breaking science in preclinical and clinical TB drug discovery and development. The talks will serve as primers for in-depth discussions on the unique challenges posed by TB relative to other infectious diseases, and topics will include how drug and target properties relate to efficacy in different models, and how these features might inform clinical trials to realize the goal of treatment shortening. Each session will be designed to address the challenges specific to the topic, and will range from early stage drug discovery to lessons learned in clinical trials.

We invite researchers interested in all aspects of drug discovery and development and welcome participants from academia, industry, government and non-governmental organizations. In particular, we invite trainees and scientists from TB-endemic countries to apply, as their contribution to the struggle against TB is especially important. All participants are asked to submit abstracts of their work for presentation as posters, and some abstracts will be chosen for oral presentations. The conference provides the opportunity to interact with colleagues in an informal and intimate atmosphere and is designed to promote extensive discussion. In the past, the meeting has been oversubscribed – please apply early!